CA1139174A - Implantable infusion device - Google Patents
Implantable infusion deviceInfo
- Publication number
- CA1139174A CA1139174A CA000346522A CA346522A CA1139174A CA 1139174 A CA1139174 A CA 1139174A CA 000346522 A CA000346522 A CA 000346522A CA 346522 A CA346522 A CA 346522A CA 1139174 A CA1139174 A CA 1139174A
- Authority
- CA
- Canada
- Prior art keywords
- reservoir
- drug
- infusion device
- catheter
- housing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
- A61M5/14276—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body specially adapted for implantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3507—Communication with implanted devices, e.g. external control
- A61M2205/3523—Communication with implanted devices, e.g. external control using telemetric means
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/12—Pressure infusion
Abstract
IMPLANTABLE INFUSION DEVICE
ABSTRACT
Multiple embodiments of an implantable infusion device for delivering precisely regulated dosages of drugs are disclosed, each device including reservoir means (16) for containing the drug, catheter means (22) for delivering the drug to the body and an actuating means (44) which is responsive to a signal applied externally of the body for initiating delivery of a precisely regulated dosage. In one embodiment, the device is implanted subcutaneously to permit actuation by a solenoid driven element responsive to coded telemetry signal applied through the skin. In additional embodiments, the reservoir is pressurized for example, by means of vapor pressure or a mechanical spring, the drug under pressure in the reservoir being released in response to an externally applied signal.
ABSTRACT
Multiple embodiments of an implantable infusion device for delivering precisely regulated dosages of drugs are disclosed, each device including reservoir means (16) for containing the drug, catheter means (22) for delivering the drug to the body and an actuating means (44) which is responsive to a signal applied externally of the body for initiating delivery of a precisely regulated dosage. In one embodiment, the device is implanted subcutaneously to permit actuation by a solenoid driven element responsive to coded telemetry signal applied through the skin. In additional embodiments, the reservoir is pressurized for example, by means of vapor pressure or a mechanical spring, the drug under pressure in the reservoir being released in response to an externally applied signal.
Description
~3~
IMPLANTABLE INFUSION DEVICE
The present invention relates to drug delivery systems and more particularly to drug infusion devices which are implanted within the body of a patient.
Various types of drug delivery systems are well known in the prior art. Possibly the most common o these systems has been employed for the delivery of drugs to bedridden patients using an elevated container with a valve controlling the drip rate of the drug into a tube coupled with a needle inserted into the patient's body. With such a system, the flow rate may be controlled by means of the valve and may be readily monitored by visual observation of the drip rate. These systems present a number of problems, not the least of which is their limitation for use only with bedridden patients.
Other types of drug delivery systems are also known which employ various types of flow control devices. For example, a drug may be delivered by ? operation of a low volume pump. All of these systems as employed within the prior art have exhibited numerous shortcomings~ For example, most systems employing pumps have bèen rather large and have required substantial amounts of power for proper operation. In addition, these devices are typically limited to use with bedridden patients~
Certain drug delivery systems have been considered for complete implantation within the body of a patient. Possibly, the most common type of device employed in this manner in the prior art has included a permeable membrane for controlled diffusion of a drug into the body from a suitable reservoir. However, such devices are limited in application primarily since the rate at which the drug is delivered to the body is completely dependent upon the rate of diffusion through ..,.
.
~3L~ 7~
the permeable membrane. Once the de-rice is implante~d within the body, external control over the device is no longer possible. Accordingly, the rate of drug delivery to the body may be affected by differing conditions S within the body. In addition, such systems make no provision for the adjustment of the rate or time interval for drug delivery.
Accordingly, there has been found to remain a need for an effective drug delivery system which may readily be employed particularly by ambulatory patients while permitting precise and preferably variable control over the rate of drug delivery to the body.
Accordingly, it is an object of the present invention to provide a drug delivery system inclucling an infusion device which i5 totally implantable within the body of a patient ~hile being responsive to a signal generated externally of the patient's body Eor causing a precisely regulated dosage of the drug to be delivered to a selected portion of the body.
Within the various preferred embodiments of the inventionr the drug is maintained within a suitable reservoir formed as a portion of the implantable device along with a catheter providing communication to a selected portion of the patient's body. In addition, the invention contemplates the inclusion of actuating means along with the implantable device, the actuating means being responsive to a signal generated or applied externally of the patient's body for causing a precisely regulated dosage of a selected drug to be delivered to the body through the catheter.
In one embodiment of the invention, the implantable infusion device may be actuated by a telemetry signal applied to activate a solenoid powered by an implanted battery. With such a device, the rate and interval for drug delivery to the body may be .
selectively controlled even with the device being completely implanted within the body.
Even more preferably, it is desirable to prevent accidental actuation of the clevice except when S it is specifically intended to cause a selected dosage of drug to be delivered into the body. For this reason, the device also preferably includes a safety latch means normally preventing delivery of the drug into the body, for example through the catheter noted above. The safety latch means is also responsive to a signal generated or applied externally of the body for selectively permitting drug delivery. In order to assure against accidental actuation of the device, the safety latch means is more preferably responsive ~o a signal dif~erent from that applied for operating the actuating means. With such an arrangement, it is ~ necessary to apply separate selected signals both for ; releasing the safety latch means and for operating the actuating mechanism of the device in order to cause the delivery of a selected drug dosage through the catheter.
In other embodiments of the drug infusion device,`the drug is pressuri~ed within the reservoir, for example, by means of vapor presure developed within a separate chamber adjacent the reservoir or through a suitable spring assembly, release of the pressurized drug into the body then being regulated by means such as a solenoid valve or the like in response to an externally applied signal. With such a combination, a specifically coded telemetry signal may be used for actuation of the solenoid valve in order to assure against accidental or undesired release of the drug to the body. However, even with drug infusion devices of this type, it is possible to also employ additional safety latch means responsive to a separate signal in order to even more positively assure that the drug is delivered to the body only when in-tended.
Such a device is contemplated to have numerous applications for delivery or administration of drugs to the body. For example, it is particularly contemplated that such a device or method could be employed to provide an artificial pancreas for delivering insulin into the body with both the rate and interval of drug administration being selectively controlled externally of the body. Numerous other applications for such a device will be apparent from the following description of the preferred embodiments.
T~e foregoing objects and advantages are provided, according to the present invention by an implantable infusion device for delivering precisely regula~ed closages of drugs under external control, comprisinc~ a housing for khe inEuslon device which is completely implantable within the body of a patient, the hous:lng including a reservoir chamber and a compressible reservoir arranged in the reservoir chamber for containing a selected drug, catheter means for connecting the reservoir with a portion of the body to which the drug is to be delivered, the housing including a pumping chamber having inlet means in communication with the reservoir and outlet means in communication with the catheter, and actuating means operable for causing flow of a precise dosage of the selected drug from the reservoir through the catheter means to the body portion, the actuating means having at least a portion implanted in the body of the patient along with the housing and including a movable element operable reciprocally to vary the volume of the pumping chamber and a csm/~
~3~
solenoid for driving the element, the reservoir chamber containing means for developing a pressure within the reserv~ir which exceeds that of the pumping chamber when the - movable element increases the volume thereof, a power source for the solenoid, and telemetry means responsive to a telemetered signal from ou-tside the body for actuating the solenoid from the power source.
FIGVRE 1 is a sectioned view illustrating internal construction of one embodiment of an implantable infusion device including mechanical actuating means for regulating drug delivery, the view of FIGURE 1 being taken along section line I-I of FIGURE 2.
FIGURE 2 is a plan view of the drug delivery or infusion device of FIGURE 1.
FIGURE 3 is.an end view of the inEusion device oE
FIGURE 1.
: FIGURE 4 is a view illustrating subcutaneous implantation of the device of FIGURE 1.
FIGURE S is a sectioned view generally similar to FIGURE 1 while illustrating yet another embodiment of : an implantable infusion device according to the present invention wherein a drug is maintained under pressure by operation of a gas cylinder and released to the body by actuation of a solenoid in response to an externally generated signal.
FIGURE 6 is a similarly sectioned view of yet another embodiment of an implantable infusion device according to the present invention wherein the drug is pressurized by mechanical spring means and similarly released by operation of a solenoid valve.
- 4a -csm/~
.
FIGURE 7 i5 also a sectioned view of yet another embodiment of an implantable infusion device according to the present invention wherein the drug is pressurized by a fluid saturated at body temperature, the pressurized drug being released to the body by actuation of a solenoid valve~
FIGURE 8 is a schematic representation of suitable electronic circuitry for use in any of the embodiments of FIGURES 5-7 to control actuation of their respective solenoid valves.
~ s summarized abover ~he method and apparatus of the present invention is described below in connection with four specific embodiments illustrated respectively in FIGURES 1-3, 5, 6 and 7.
Each of these embodiments provides a drug infusion device or delivery system which may be completely implanted wi~hin the body o~ a patient to deliver a selected drug to the body. Most importantly, both the rate and interval of drug delivery to the body may be selectively controlled by an actuating signal generated or applied externally of the body~
Accordlngly, each of the four embodiments demonstrates means for carrying out a method of selectively releasing precisely regulated dosages of a drug to the body of a patient from a reservoir implanted within the body but in response to a signal generated or applied externally of the body. As noted above, the embodiment of FIGURES
1-3 comtemplates application of a coded telemetry actuating signal directly through the skin, to cause energization of a solenoid from an implanted battery.
In each of the embodiments of FIGURES 5-7, the.drug is placed under pressure within a reservoir of the device while its rate and interval of release from the device i5 regulated by suitable means, preferably a solenoid valve, in response to an externally generated signal, preferably a coded telemetry signal.
In describing the embodimentc of FIGURES 1-3 in greater detail, having reference to those FIGURES, an implantable infusion device is generally indicated at 10 and includes a rigid housing 12 preferably formed from stainless steel or titanium. The stainless steel or titanium housing 12 is encased with a sheath 14 of a material designed for compati~ility with the body, preferably a biocompatible polymer such as silicone rubber or polyurethane.
The interior of the housing 12 is generally divided into three regions including a reservoir portion 16, a pumping chamber portion 18 and an outlet portion 20 arranged or communication with a catheter 22 which is disposed outside of the housing 12. The entire housing 12 is also slightly curved as may be best seen in FIGURE 3 in order to better adapt the device to the body configuration when it i5 implanted in the manner shown for example in FIGURE 4.
The reservoir portion 16 of the device is separately ormed by the housing 12 and urther includes a distendible bladder 24 for containing a selected drug. A metal bellows could also be used for the same purpose. A wall portion 26 of the housing 12 which is arranged between the reservoir 16 and pumping chamber 18 forms an opening 28 with the interior o the bladcler 24 being in communication with the pumping chamber 18 through the opening. However, the opening is normally closed by an inlet check valve 30 which operates in a manner desribed in greater detail below to regulate communication of the fluid drug in the bladder into the pumping chamber.
The housing 12 also includes internal structure forming a plurality of outlet chambers providing serial communication between the pumping chamber and the catheter. The outlet chambers are indicated respectively at 32, 34 and 36, the outlet chamber 36 being a final chamber which is in direct communication with the catheter 22. A separate outlet check valve respectively regulates communication of a drug from the pumping chamber into the first outlet chamber 32, from the outlet chamber 32 into the next chamber 34 and from the chamber 34 into the final outlet chamber 36 and accordingly into the catheter 22. The check valves are indicated respectively at 38, 40 and 42. Preferably, one of the check valves, indicated at 40, is of a separate type or design in order to better assure operation of the serial arrangement of check valves under all conditions.
Actuation of the device is accomplished by means of a mechanical plunger 44 which is arran~ed outside of the housing 12 so that an actuating force may be directly applied to the plunger. The plunger extends through an opening in thè housing 12 into the pumping ^ 20 chamber where it is connected with a piston bellows 46.
Thus, mechanical actuation or depression of the plunger tends to pressuri~e the pumping chamber causing the flow of a drug through the check valves 38-42 and into the catheter. Upon release of the plunger, it is urged into its extended position as illustrated in ~IGU~E 1 by spring action of the piston bellows. In this manner, the volume of the pumping chamber is again diminished so that fluid drug from the bladder 24 passes through the inlet check valve 30 to again fill the pumping chamber.
As indicated above, it is particularly desirable to assure that operation of the infusion device takes place only when properly intended.
Accordingly, a safety latch assembly 48 is provided which prevents operation of the device unless separate externally generated or applied signals are caused to operate both the safety latch assembly 48 and the plunger 44.
The safety latch assembly could take many different forms. For example, it might be in the form of a valve blocking communication Erom the final outlet chamber 36 into the catheter. Elowever, the safety latch assembly 48 is preferably a mechaniccll latching unit for preventing movement of the plunger 44 except when two separate actuating signals are applied as described above. For this reason, the safety latch assembly 48 includes a plunger latching member 50 which is urged into locking engagement with the plunger 44 by means of a latch spring 52. An unlatching paddle 54 is formed as a bell-crank coupled with the unlatching paddle 54 and having a magnetic arm 56.
A magnetic signal may thus be applied to the magnetic arm when the device is implanted within the body for causing the latchin~ member 50 to shi~t against the spring 52 and thereafter permits mechanical operation of the plunger 44. The housing around the safety latch is formed from a non-magnetic material such as stainless steel or plastic with a rigid extension 58 extending outwardly around the safety latch assembly 48. As noted above, the plunger 44, is covered only by the elastic coating 14 to permit its mechanical actuation. As an alternative, the latch may be operated by a suitable device such as a solenoid ~not shown) operated by a control (not shown) responsive to a telemetry signal generated outside the body.
Referring momentarily to FIGURES 1-3 in combination, it may be seen that the overall configuration of the device as best seen in FIGURE 3 includes a convex side 60 upon which side the plunger 44 has solenoid positioned to cause axial movement of the plunger in response to signals applied to the solenoid.
The solenoid is powered from a battery 65, "II.t;j~
_9 _ controlled by a telemetry receiver 67 of suitable design. The battery 65 and receiver 67 are implantable and are completely covered by a sheath 69 of biocompatible material. ~s an alternative, the battery 65 and receiver 67 may be enclosed within the sheath 14.
On the same side of the device, the housing 12 forms an additional opening 64 through which the drug supply within the bladder 24 may be replenished. An additional check valve 66 is arranged within the opening 1~ 64 to permlt a fluid drug to be injected into the bladder while preventing the drug from escaping out of the bladder through the opening 64. The coating 14 for the housing thus forms a resealable septum ahove the opening 64 allowing a needle to be inserted through the skin, the coating septum and the opening 64 for injecting a Eresh supply of drugs into the reservoir or bladder 24. Upon retraction of the needle, the opening 64 is again closed by the check valve 66 so that the drug may be supplied to the body only by proper operation of the plunger and latching assembly as described above. The housing 12 is also formed with an annular ridge 68 surrounding the opening 64 in order to assist in location of the opening 64 for injection of the drug into the reservoir.
In operation of the embodiment of FIGURE 1, the device is subcutaneously implanted within the body as illustrated in FIGURE 4 with the housing opening 64 being exposed just beneath the skin. A fresh supply of drug is injected into the reservoir or bladder through the opening 64 and check valve 66 as described above.
The drug within the bladder is placed under constant pressure, preferably by means of a fluid such as Trichloroflouromethane CCL3F (Freon II ~ - DuPont) for example and disposed within the housing about the bladder 24. At body temperature, vaporization of the ~3~ 7~
fluid tends to exert a limited but constant positive pressure upon the bladder.
As indicated above, operation of the plunger 44 is accomplished by external application oE a magnetic signal upon the safety latch assembly 48 followed by ~he application of a telemetry signal to actuate the plunger 44. The plunger may be actuated one or more times to cause a carefully regulated volume or dosage of drug from the pumping chamber to pass through the outlet -chambers 32-36 and the check valves 38-42 into the catheter 22 for delivery to the body. As fluid is expelled from the pumping chamber by depression of tlle plunger, additional drug passes into the pumping chamber ~rom the bladder by operation of the inlet check valve 30 when the plunger is again retracted.
Thus, a relatively large dosage o~ drugs may be implanted within the body and assured agaillst undesired delivery to the body except by externally controlled operation o the infusion device in the manner described above.
Unlike the embodiment of FIGURES 1-3, each of the embodiments of FIGURES 5-7 includes dif~erent means for placing a reservoir of a selected drug under pressure with outlet means such as a solenoid valve being operable in response to an externally applied signal for releasing closely regulated dosages of tlle drug to the body.
Referring first to FIGURE 5, another embodiment of an implantable infusion device is inclicated at 110 and includes a housing 112 which may be covered by a coating 114 generally similar to that indicated at 14 in FIGURE 1. A drug reservoir is formed adjacent one end of the housing 112 by a bellows 116.
Pressure is applied to the drug within the bellows by means of a gas spring cylinder assembly 118 comprising a piston 120 slidably arranged within a cylinder 122 and connected to a rod ]24 which is also secured to the collapsible bellows 116. The piston 120 has a small hole 126 which permits equalization of pressure upon both sides of the piston. The cylinder is ~illed with a suitable inert gas such as nitrogen or argon. The piston is urged leftwardly within the cylinder, as viewed in FIGURE 5, because of the differential effective area of the piston formed by the rod 12~. The variation in pressure acting on the drug as the drug is used up is compensated by adjusting the "open" duration of the solenoid valve.
~ catheter 1~8 extendillg from the housi1lg 112 is in communication with the drug reservoir formecl by he bellows 116. Communication between the bellows reservoir and the catheter is regulated by suitable means such as a solenoid valve 130. The solenoid valve 130 normally limits communication o~ the drug from the bellows reservoir to the catheter. Electronic circuitry for actuating the solenoid valve 130 is indicated generally at 132 and is arranged peripherally about the gas spring cylinder assembly 118. A typical example of circuitry which might be employed within the device is illustrated in FIGU~E 8 and described in greater detail below. For the present, it is noted that the circuitry is responsive to an externally applied signal, preferably a coded telemetry signal for actuating the solenoid valve and causing a closely regulated dosage of the drug to be delivered to the body.
The dosage of drug delivered to the body is of course determined both by the size of the opening provided between the reservoir and the catheter by the solenoid valve as well as by the pressure developed upon the bellows by the cylinder assembly 118. The amount of time during which the solenoid valve 13~ remains open b~ ll 7 .~
can of course be closely established or may even be~
varied under the regulation of the circuitry 132 in order to deliver variable or constant dosages of drugs to the body as determined by the externally geneated S signal applied to the circuitry 132.
It is also noted in FIGURE S that the undesired delivery of drugs to the body may be prevented by designing the circuitry 132 so that it only functions in response to a carefully coded telemetry signal.
However, it would also be possible to employ a safety latching assembly generally of the type indicated at 48 in FIG~RE 1 to even further assure against undesirable delivery of a drug to the body~ Here again, such a safety latch assembly could operate in response to a lS separate signal from that employed for actuation of the solenoid valve 130 through the circuitry 132~
Another embodiment of an implantable in~usion device is indica~ed at 210 in FIGURE 6 and is generally simi}.ar to the embodiment of FIGURE S. Accordingly, similar components of the device of FIGURE 6 are indicated by corresponding numerical labels used in FIGURE S but preceded by the digit "2". Generally, in FIGURE 6, a drug within the bellows reservoir is pressurized by means of a mechanical spring assembly 234 instead of the gas cylinder assembly of FIGURE 5. The mechanical spring assembly 234 preferably includes a plurality of constant-force extendible coil springs 236. The axes 238 of the spring coils 236 are secured relative to the housing 212. The extended ends 240 of the spring coils are secured to a plunger 242 which acts upon the bellows 216. Thus, the spring coils tend to apply a low intensity, constant-force to the bellows for developiny a small positive pressure on the drug contained within the bellows reservoir. The solenoid valve 230 functions in response to circuitry 232 for , .
regulating communication of the drug from the bellows reservoir into the catheter 228 for delivery into the "
body. Here again, a suitable example of circuitry employable within the device of FIGURE 6 is described below and illustrated in FIGURE 8.
The emhodiment of FIGURE 7 is also very similar to those described above in connection with FIGURES 5 and 6. Accordingly, similar componerlts of the device 31~ of FIGURE 7 are indicated by similar numerals lQ preceded by the digit "3". Within the embodiment of FIGURE 7, fluid pressure is again employed within the housing 312 to develop a small but constant positive pressure upon the bellows 316 and the drug contained therein. ~owever, the fluid pressure is merely developed within a cavity formed by the housing 312 so that the fluid pressure completely surrounds the bellows 316. Thus, the constant vapor pressure developed by the fluid at body temperature produces the pressure which acts upon the bellows 316. Here again, the solenoid valve 330 is actuated by the circuitry 332 for closely regulating the communication of the drug from the bellows reservoir into the catheter 328 for delivery to the body.
It is also noted that a safety latch assembly similar to that described at 48 in FIGURE 1 could also be employed within the embodiments of FIGURES 6 and 7.
However, within the embodiments of FIGURES 5-7, such a safety latch assembly would have to be designed for limiting communication of the drug into the catheter rather than for acting as a mechanical detent in the manner illustrated in FIGURE 1.
Before proceeding with a description of the control circuit illustrated in FIGURE 8, it is again noted that within each of the embodiments of FIGURES
5-7, regulation over drug delivery to the body is particularly dependent upon operation of the solenoid valve indicated at 130, 230 or 330. Preferably, the solenoid valve is load matched to integral valve means, for example a needle valve (not shown) J by means of a spring (also not shown) which results in quiet controlled solenoid closure without significant impact force. In addition, with such a solenoid valve, it may be operated by a minimum amount of energy permitting any of the devices of FIGURES 5-7 to operate over extended periods o~ time on conventional battery power. ~s was indicated above, in each of the embodiments of FIGURES
5-7, the drug is maintained under constant low pressure within a bellows reservoir, the solenoid valve serving as a "gate" to release the drug from the bellows reservoir for delivery to the body through the catheter.
Flow metering could be accomplished for example in either of two different ways by a solenoid v~lve. In the first, the solenoid valve would open and close with no substantial dwell period in its open condition, flow taking place during the opening and closing of the valve. The quantity or dosage of drug delivered to the body would be determined by the number of opening and closing cycles experienced by the valve. Alternatively, a bistable solenoid valve could be employed which would remain in an open condition for a predetermined period of timeO Such a valve could possibly be opened either magnetically or mechanically. Release of the valve to its closed condition could then be accomplished electrically within the solenoid.
With any such arrangement, it is only necessary to provide circuitry to assure that the solenoid either remains open for a selected period of time to release a controlled drug dosage or that a solenoid valve having a natural frequency is caused to open and close through a selected number of cycles to accomplish delivery of a ~9.~.7~
selected drug dosage. Circuits for accomplishing these functions are well known in the prior art and FIGURE 8 is a schematic illustration of a simple circuit which could possible by employed for regulating operation of the solenoid valve.
Referring now to FIGURE 8, the control circuit which is also gene~ally indicated in FIGURES 5-7 at 132, 232, or 332, comprises a battery 410, a transistor switch 412 for regulating operation of the normally closed solenoid valve, a diode 414 and a permanent magnet 416. Control components for regulating operation of the transistor switch 412 include a drive amplifier 418 for delivering to the switch 412 a signal produced b~ the other control components including`a pro~ramming device 420, a logic unit 422, and a timiny Ullit or cloc~
4~4. The programming device 420 is adapted to receive an externally generated or applied signal, preferably a coded telemetry signal.
In operation, when a coded signal is received by the programming device 420 and applied through the drive amplifier 418, the switch is actuated, causing current from the battery 410-to flow through the switch into the magnet 416 and to increase to a value determined primarily by the resistance of the magnet and the voltage of the battery. These components are selected so that the current is sufficient to operate the solenoid valves of any of FIGURES 5-7.
When the switch 412 i5 deactuated by termination of the signal from the drive amplifier 418, the current in the magnet flows through the diode 414 and decays according to the time constant of the magnet. When the current decays to the selected level, the solenoid valve again closes. In a preferred mode of operation, the logic unit 422 develops a pulse train of a series of short signals in response to the programmin~
device 420, the signals from the logic unit beinq ~ery -~
short so that they are substantially less than ~he natural period of vibration for armature (not shown) of the solenoid valve. With such an arrangement, all opening cycles of the solenoid valve would be established by the above noted natural period of vibration. The logic unit 422 would then be employed to generate the number o~ such pulses corresponding to a count previously stored in the programming device 420.
Such a series of pulses would be produced for each programmed clock period established by the continuously operating timing unit 424.
Alternatively, in a single pulse mode, the transistor switch 412 could be turned on for a period to assure actuation of the solenoid valve. The currellt delivered to the magnet 416 could then be reduced ~o a load level sufficient for holding the valve in an open condition or else a series of current pulses could be delivered, each pulse being much shorter than the time constant of the magnet. With a relatively long time constant or the magnet, such pulses would cause little fluctuation of the effective current. Such an arrangement is a standard means for lowering the effective DC circuit voltage without high dissipation.
In this mode of operation, such a reduced "holding current" would be maintained for a programmed number of clock pulses and as established by the timing unit 424 after which the logic unit 422 would te~minate the signal through the drive amplifier 418 with the transistor switch 412 being closed to deactuate the solenoid valve.
It is believed apparent that numerous modifications and variations are possible within the scope of the present invention as defined by the various embodiments set forth above. Accordingly, the scope of ,t~J~
the present invention is defined only by the following appended claims.
IMPLANTABLE INFUSION DEVICE
The present invention relates to drug delivery systems and more particularly to drug infusion devices which are implanted within the body of a patient.
Various types of drug delivery systems are well known in the prior art. Possibly the most common o these systems has been employed for the delivery of drugs to bedridden patients using an elevated container with a valve controlling the drip rate of the drug into a tube coupled with a needle inserted into the patient's body. With such a system, the flow rate may be controlled by means of the valve and may be readily monitored by visual observation of the drip rate. These systems present a number of problems, not the least of which is their limitation for use only with bedridden patients.
Other types of drug delivery systems are also known which employ various types of flow control devices. For example, a drug may be delivered by ? operation of a low volume pump. All of these systems as employed within the prior art have exhibited numerous shortcomings~ For example, most systems employing pumps have bèen rather large and have required substantial amounts of power for proper operation. In addition, these devices are typically limited to use with bedridden patients~
Certain drug delivery systems have been considered for complete implantation within the body of a patient. Possibly, the most common type of device employed in this manner in the prior art has included a permeable membrane for controlled diffusion of a drug into the body from a suitable reservoir. However, such devices are limited in application primarily since the rate at which the drug is delivered to the body is completely dependent upon the rate of diffusion through ..,.
.
~3L~ 7~
the permeable membrane. Once the de-rice is implante~d within the body, external control over the device is no longer possible. Accordingly, the rate of drug delivery to the body may be affected by differing conditions S within the body. In addition, such systems make no provision for the adjustment of the rate or time interval for drug delivery.
Accordingly, there has been found to remain a need for an effective drug delivery system which may readily be employed particularly by ambulatory patients while permitting precise and preferably variable control over the rate of drug delivery to the body.
Accordingly, it is an object of the present invention to provide a drug delivery system inclucling an infusion device which i5 totally implantable within the body of a patient ~hile being responsive to a signal generated externally of the patient's body Eor causing a precisely regulated dosage of the drug to be delivered to a selected portion of the body.
Within the various preferred embodiments of the inventionr the drug is maintained within a suitable reservoir formed as a portion of the implantable device along with a catheter providing communication to a selected portion of the patient's body. In addition, the invention contemplates the inclusion of actuating means along with the implantable device, the actuating means being responsive to a signal generated or applied externally of the patient's body for causing a precisely regulated dosage of a selected drug to be delivered to the body through the catheter.
In one embodiment of the invention, the implantable infusion device may be actuated by a telemetry signal applied to activate a solenoid powered by an implanted battery. With such a device, the rate and interval for drug delivery to the body may be .
selectively controlled even with the device being completely implanted within the body.
Even more preferably, it is desirable to prevent accidental actuation of the clevice except when S it is specifically intended to cause a selected dosage of drug to be delivered into the body. For this reason, the device also preferably includes a safety latch means normally preventing delivery of the drug into the body, for example through the catheter noted above. The safety latch means is also responsive to a signal generated or applied externally of the body for selectively permitting drug delivery. In order to assure against accidental actuation of the device, the safety latch means is more preferably responsive ~o a signal dif~erent from that applied for operating the actuating means. With such an arrangement, it is ~ necessary to apply separate selected signals both for ; releasing the safety latch means and for operating the actuating mechanism of the device in order to cause the delivery of a selected drug dosage through the catheter.
In other embodiments of the drug infusion device,`the drug is pressuri~ed within the reservoir, for example, by means of vapor presure developed within a separate chamber adjacent the reservoir or through a suitable spring assembly, release of the pressurized drug into the body then being regulated by means such as a solenoid valve or the like in response to an externally applied signal. With such a combination, a specifically coded telemetry signal may be used for actuation of the solenoid valve in order to assure against accidental or undesired release of the drug to the body. However, even with drug infusion devices of this type, it is possible to also employ additional safety latch means responsive to a separate signal in order to even more positively assure that the drug is delivered to the body only when in-tended.
Such a device is contemplated to have numerous applications for delivery or administration of drugs to the body. For example, it is particularly contemplated that such a device or method could be employed to provide an artificial pancreas for delivering insulin into the body with both the rate and interval of drug administration being selectively controlled externally of the body. Numerous other applications for such a device will be apparent from the following description of the preferred embodiments.
T~e foregoing objects and advantages are provided, according to the present invention by an implantable infusion device for delivering precisely regula~ed closages of drugs under external control, comprisinc~ a housing for khe inEuslon device which is completely implantable within the body of a patient, the hous:lng including a reservoir chamber and a compressible reservoir arranged in the reservoir chamber for containing a selected drug, catheter means for connecting the reservoir with a portion of the body to which the drug is to be delivered, the housing including a pumping chamber having inlet means in communication with the reservoir and outlet means in communication with the catheter, and actuating means operable for causing flow of a precise dosage of the selected drug from the reservoir through the catheter means to the body portion, the actuating means having at least a portion implanted in the body of the patient along with the housing and including a movable element operable reciprocally to vary the volume of the pumping chamber and a csm/~
~3~
solenoid for driving the element, the reservoir chamber containing means for developing a pressure within the reserv~ir which exceeds that of the pumping chamber when the - movable element increases the volume thereof, a power source for the solenoid, and telemetry means responsive to a telemetered signal from ou-tside the body for actuating the solenoid from the power source.
FIGVRE 1 is a sectioned view illustrating internal construction of one embodiment of an implantable infusion device including mechanical actuating means for regulating drug delivery, the view of FIGURE 1 being taken along section line I-I of FIGURE 2.
FIGURE 2 is a plan view of the drug delivery or infusion device of FIGURE 1.
FIGURE 3 is.an end view of the inEusion device oE
FIGURE 1.
: FIGURE 4 is a view illustrating subcutaneous implantation of the device of FIGURE 1.
FIGURE S is a sectioned view generally similar to FIGURE 1 while illustrating yet another embodiment of : an implantable infusion device according to the present invention wherein a drug is maintained under pressure by operation of a gas cylinder and released to the body by actuation of a solenoid in response to an externally generated signal.
FIGURE 6 is a similarly sectioned view of yet another embodiment of an implantable infusion device according to the present invention wherein the drug is pressurized by mechanical spring means and similarly released by operation of a solenoid valve.
- 4a -csm/~
.
FIGURE 7 i5 also a sectioned view of yet another embodiment of an implantable infusion device according to the present invention wherein the drug is pressurized by a fluid saturated at body temperature, the pressurized drug being released to the body by actuation of a solenoid valve~
FIGURE 8 is a schematic representation of suitable electronic circuitry for use in any of the embodiments of FIGURES 5-7 to control actuation of their respective solenoid valves.
~ s summarized abover ~he method and apparatus of the present invention is described below in connection with four specific embodiments illustrated respectively in FIGURES 1-3, 5, 6 and 7.
Each of these embodiments provides a drug infusion device or delivery system which may be completely implanted wi~hin the body o~ a patient to deliver a selected drug to the body. Most importantly, both the rate and interval of drug delivery to the body may be selectively controlled by an actuating signal generated or applied externally of the body~
Accordlngly, each of the four embodiments demonstrates means for carrying out a method of selectively releasing precisely regulated dosages of a drug to the body of a patient from a reservoir implanted within the body but in response to a signal generated or applied externally of the body. As noted above, the embodiment of FIGURES
1-3 comtemplates application of a coded telemetry actuating signal directly through the skin, to cause energization of a solenoid from an implanted battery.
In each of the embodiments of FIGURES 5-7, the.drug is placed under pressure within a reservoir of the device while its rate and interval of release from the device i5 regulated by suitable means, preferably a solenoid valve, in response to an externally generated signal, preferably a coded telemetry signal.
In describing the embodimentc of FIGURES 1-3 in greater detail, having reference to those FIGURES, an implantable infusion device is generally indicated at 10 and includes a rigid housing 12 preferably formed from stainless steel or titanium. The stainless steel or titanium housing 12 is encased with a sheath 14 of a material designed for compati~ility with the body, preferably a biocompatible polymer such as silicone rubber or polyurethane.
The interior of the housing 12 is generally divided into three regions including a reservoir portion 16, a pumping chamber portion 18 and an outlet portion 20 arranged or communication with a catheter 22 which is disposed outside of the housing 12. The entire housing 12 is also slightly curved as may be best seen in FIGURE 3 in order to better adapt the device to the body configuration when it i5 implanted in the manner shown for example in FIGURE 4.
The reservoir portion 16 of the device is separately ormed by the housing 12 and urther includes a distendible bladder 24 for containing a selected drug. A metal bellows could also be used for the same purpose. A wall portion 26 of the housing 12 which is arranged between the reservoir 16 and pumping chamber 18 forms an opening 28 with the interior o the bladcler 24 being in communication with the pumping chamber 18 through the opening. However, the opening is normally closed by an inlet check valve 30 which operates in a manner desribed in greater detail below to regulate communication of the fluid drug in the bladder into the pumping chamber.
The housing 12 also includes internal structure forming a plurality of outlet chambers providing serial communication between the pumping chamber and the catheter. The outlet chambers are indicated respectively at 32, 34 and 36, the outlet chamber 36 being a final chamber which is in direct communication with the catheter 22. A separate outlet check valve respectively regulates communication of a drug from the pumping chamber into the first outlet chamber 32, from the outlet chamber 32 into the next chamber 34 and from the chamber 34 into the final outlet chamber 36 and accordingly into the catheter 22. The check valves are indicated respectively at 38, 40 and 42. Preferably, one of the check valves, indicated at 40, is of a separate type or design in order to better assure operation of the serial arrangement of check valves under all conditions.
Actuation of the device is accomplished by means of a mechanical plunger 44 which is arran~ed outside of the housing 12 so that an actuating force may be directly applied to the plunger. The plunger extends through an opening in thè housing 12 into the pumping ^ 20 chamber where it is connected with a piston bellows 46.
Thus, mechanical actuation or depression of the plunger tends to pressuri~e the pumping chamber causing the flow of a drug through the check valves 38-42 and into the catheter. Upon release of the plunger, it is urged into its extended position as illustrated in ~IGU~E 1 by spring action of the piston bellows. In this manner, the volume of the pumping chamber is again diminished so that fluid drug from the bladder 24 passes through the inlet check valve 30 to again fill the pumping chamber.
As indicated above, it is particularly desirable to assure that operation of the infusion device takes place only when properly intended.
Accordingly, a safety latch assembly 48 is provided which prevents operation of the device unless separate externally generated or applied signals are caused to operate both the safety latch assembly 48 and the plunger 44.
The safety latch assembly could take many different forms. For example, it might be in the form of a valve blocking communication Erom the final outlet chamber 36 into the catheter. Elowever, the safety latch assembly 48 is preferably a mechaniccll latching unit for preventing movement of the plunger 44 except when two separate actuating signals are applied as described above. For this reason, the safety latch assembly 48 includes a plunger latching member 50 which is urged into locking engagement with the plunger 44 by means of a latch spring 52. An unlatching paddle 54 is formed as a bell-crank coupled with the unlatching paddle 54 and having a magnetic arm 56.
A magnetic signal may thus be applied to the magnetic arm when the device is implanted within the body for causing the latchin~ member 50 to shi~t against the spring 52 and thereafter permits mechanical operation of the plunger 44. The housing around the safety latch is formed from a non-magnetic material such as stainless steel or plastic with a rigid extension 58 extending outwardly around the safety latch assembly 48. As noted above, the plunger 44, is covered only by the elastic coating 14 to permit its mechanical actuation. As an alternative, the latch may be operated by a suitable device such as a solenoid ~not shown) operated by a control (not shown) responsive to a telemetry signal generated outside the body.
Referring momentarily to FIGURES 1-3 in combination, it may be seen that the overall configuration of the device as best seen in FIGURE 3 includes a convex side 60 upon which side the plunger 44 has solenoid positioned to cause axial movement of the plunger in response to signals applied to the solenoid.
The solenoid is powered from a battery 65, "II.t;j~
_9 _ controlled by a telemetry receiver 67 of suitable design. The battery 65 and receiver 67 are implantable and are completely covered by a sheath 69 of biocompatible material. ~s an alternative, the battery 65 and receiver 67 may be enclosed within the sheath 14.
On the same side of the device, the housing 12 forms an additional opening 64 through which the drug supply within the bladder 24 may be replenished. An additional check valve 66 is arranged within the opening 1~ 64 to permlt a fluid drug to be injected into the bladder while preventing the drug from escaping out of the bladder through the opening 64. The coating 14 for the housing thus forms a resealable septum ahove the opening 64 allowing a needle to be inserted through the skin, the coating septum and the opening 64 for injecting a Eresh supply of drugs into the reservoir or bladder 24. Upon retraction of the needle, the opening 64 is again closed by the check valve 66 so that the drug may be supplied to the body only by proper operation of the plunger and latching assembly as described above. The housing 12 is also formed with an annular ridge 68 surrounding the opening 64 in order to assist in location of the opening 64 for injection of the drug into the reservoir.
In operation of the embodiment of FIGURE 1, the device is subcutaneously implanted within the body as illustrated in FIGURE 4 with the housing opening 64 being exposed just beneath the skin. A fresh supply of drug is injected into the reservoir or bladder through the opening 64 and check valve 66 as described above.
The drug within the bladder is placed under constant pressure, preferably by means of a fluid such as Trichloroflouromethane CCL3F (Freon II ~ - DuPont) for example and disposed within the housing about the bladder 24. At body temperature, vaporization of the ~3~ 7~
fluid tends to exert a limited but constant positive pressure upon the bladder.
As indicated above, operation of the plunger 44 is accomplished by external application oE a magnetic signal upon the safety latch assembly 48 followed by ~he application of a telemetry signal to actuate the plunger 44. The plunger may be actuated one or more times to cause a carefully regulated volume or dosage of drug from the pumping chamber to pass through the outlet -chambers 32-36 and the check valves 38-42 into the catheter 22 for delivery to the body. As fluid is expelled from the pumping chamber by depression of tlle plunger, additional drug passes into the pumping chamber ~rom the bladder by operation of the inlet check valve 30 when the plunger is again retracted.
Thus, a relatively large dosage o~ drugs may be implanted within the body and assured agaillst undesired delivery to the body except by externally controlled operation o the infusion device in the manner described above.
Unlike the embodiment of FIGURES 1-3, each of the embodiments of FIGURES 5-7 includes dif~erent means for placing a reservoir of a selected drug under pressure with outlet means such as a solenoid valve being operable in response to an externally applied signal for releasing closely regulated dosages of tlle drug to the body.
Referring first to FIGURE 5, another embodiment of an implantable infusion device is inclicated at 110 and includes a housing 112 which may be covered by a coating 114 generally similar to that indicated at 14 in FIGURE 1. A drug reservoir is formed adjacent one end of the housing 112 by a bellows 116.
Pressure is applied to the drug within the bellows by means of a gas spring cylinder assembly 118 comprising a piston 120 slidably arranged within a cylinder 122 and connected to a rod ]24 which is also secured to the collapsible bellows 116. The piston 120 has a small hole 126 which permits equalization of pressure upon both sides of the piston. The cylinder is ~illed with a suitable inert gas such as nitrogen or argon. The piston is urged leftwardly within the cylinder, as viewed in FIGURE 5, because of the differential effective area of the piston formed by the rod 12~. The variation in pressure acting on the drug as the drug is used up is compensated by adjusting the "open" duration of the solenoid valve.
~ catheter 1~8 extendillg from the housi1lg 112 is in communication with the drug reservoir formecl by he bellows 116. Communication between the bellows reservoir and the catheter is regulated by suitable means such as a solenoid valve 130. The solenoid valve 130 normally limits communication o~ the drug from the bellows reservoir to the catheter. Electronic circuitry for actuating the solenoid valve 130 is indicated generally at 132 and is arranged peripherally about the gas spring cylinder assembly 118. A typical example of circuitry which might be employed within the device is illustrated in FIGU~E 8 and described in greater detail below. For the present, it is noted that the circuitry is responsive to an externally applied signal, preferably a coded telemetry signal for actuating the solenoid valve and causing a closely regulated dosage of the drug to be delivered to the body.
The dosage of drug delivered to the body is of course determined both by the size of the opening provided between the reservoir and the catheter by the solenoid valve as well as by the pressure developed upon the bellows by the cylinder assembly 118. The amount of time during which the solenoid valve 13~ remains open b~ ll 7 .~
can of course be closely established or may even be~
varied under the regulation of the circuitry 132 in order to deliver variable or constant dosages of drugs to the body as determined by the externally geneated S signal applied to the circuitry 132.
It is also noted in FIGURE S that the undesired delivery of drugs to the body may be prevented by designing the circuitry 132 so that it only functions in response to a carefully coded telemetry signal.
However, it would also be possible to employ a safety latching assembly generally of the type indicated at 48 in FIG~RE 1 to even further assure against undesirable delivery of a drug to the body~ Here again, such a safety latch assembly could operate in response to a lS separate signal from that employed for actuation of the solenoid valve 130 through the circuitry 132~
Another embodiment of an implantable in~usion device is indica~ed at 210 in FIGURE 6 and is generally simi}.ar to the embodiment of FIGURE S. Accordingly, similar components of the device of FIGURE 6 are indicated by corresponding numerical labels used in FIGURE S but preceded by the digit "2". Generally, in FIGURE 6, a drug within the bellows reservoir is pressurized by means of a mechanical spring assembly 234 instead of the gas cylinder assembly of FIGURE 5. The mechanical spring assembly 234 preferably includes a plurality of constant-force extendible coil springs 236. The axes 238 of the spring coils 236 are secured relative to the housing 212. The extended ends 240 of the spring coils are secured to a plunger 242 which acts upon the bellows 216. Thus, the spring coils tend to apply a low intensity, constant-force to the bellows for developiny a small positive pressure on the drug contained within the bellows reservoir. The solenoid valve 230 functions in response to circuitry 232 for , .
regulating communication of the drug from the bellows reservoir into the catheter 228 for delivery into the "
body. Here again, a suitable example of circuitry employable within the device of FIGURE 6 is described below and illustrated in FIGURE 8.
The emhodiment of FIGURE 7 is also very similar to those described above in connection with FIGURES 5 and 6. Accordingly, similar componerlts of the device 31~ of FIGURE 7 are indicated by similar numerals lQ preceded by the digit "3". Within the embodiment of FIGURE 7, fluid pressure is again employed within the housing 312 to develop a small but constant positive pressure upon the bellows 316 and the drug contained therein. ~owever, the fluid pressure is merely developed within a cavity formed by the housing 312 so that the fluid pressure completely surrounds the bellows 316. Thus, the constant vapor pressure developed by the fluid at body temperature produces the pressure which acts upon the bellows 316. Here again, the solenoid valve 330 is actuated by the circuitry 332 for closely regulating the communication of the drug from the bellows reservoir into the catheter 328 for delivery to the body.
It is also noted that a safety latch assembly similar to that described at 48 in FIGURE 1 could also be employed within the embodiments of FIGURES 6 and 7.
However, within the embodiments of FIGURES 5-7, such a safety latch assembly would have to be designed for limiting communication of the drug into the catheter rather than for acting as a mechanical detent in the manner illustrated in FIGURE 1.
Before proceeding with a description of the control circuit illustrated in FIGURE 8, it is again noted that within each of the embodiments of FIGURES
5-7, regulation over drug delivery to the body is particularly dependent upon operation of the solenoid valve indicated at 130, 230 or 330. Preferably, the solenoid valve is load matched to integral valve means, for example a needle valve (not shown) J by means of a spring (also not shown) which results in quiet controlled solenoid closure without significant impact force. In addition, with such a solenoid valve, it may be operated by a minimum amount of energy permitting any of the devices of FIGURES 5-7 to operate over extended periods o~ time on conventional battery power. ~s was indicated above, in each of the embodiments of FIGURES
5-7, the drug is maintained under constant low pressure within a bellows reservoir, the solenoid valve serving as a "gate" to release the drug from the bellows reservoir for delivery to the body through the catheter.
Flow metering could be accomplished for example in either of two different ways by a solenoid v~lve. In the first, the solenoid valve would open and close with no substantial dwell period in its open condition, flow taking place during the opening and closing of the valve. The quantity or dosage of drug delivered to the body would be determined by the number of opening and closing cycles experienced by the valve. Alternatively, a bistable solenoid valve could be employed which would remain in an open condition for a predetermined period of timeO Such a valve could possibly be opened either magnetically or mechanically. Release of the valve to its closed condition could then be accomplished electrically within the solenoid.
With any such arrangement, it is only necessary to provide circuitry to assure that the solenoid either remains open for a selected period of time to release a controlled drug dosage or that a solenoid valve having a natural frequency is caused to open and close through a selected number of cycles to accomplish delivery of a ~9.~.7~
selected drug dosage. Circuits for accomplishing these functions are well known in the prior art and FIGURE 8 is a schematic illustration of a simple circuit which could possible by employed for regulating operation of the solenoid valve.
Referring now to FIGURE 8, the control circuit which is also gene~ally indicated in FIGURES 5-7 at 132, 232, or 332, comprises a battery 410, a transistor switch 412 for regulating operation of the normally closed solenoid valve, a diode 414 and a permanent magnet 416. Control components for regulating operation of the transistor switch 412 include a drive amplifier 418 for delivering to the switch 412 a signal produced b~ the other control components including`a pro~ramming device 420, a logic unit 422, and a timiny Ullit or cloc~
4~4. The programming device 420 is adapted to receive an externally generated or applied signal, preferably a coded telemetry signal.
In operation, when a coded signal is received by the programming device 420 and applied through the drive amplifier 418, the switch is actuated, causing current from the battery 410-to flow through the switch into the magnet 416 and to increase to a value determined primarily by the resistance of the magnet and the voltage of the battery. These components are selected so that the current is sufficient to operate the solenoid valves of any of FIGURES 5-7.
When the switch 412 i5 deactuated by termination of the signal from the drive amplifier 418, the current in the magnet flows through the diode 414 and decays according to the time constant of the magnet. When the current decays to the selected level, the solenoid valve again closes. In a preferred mode of operation, the logic unit 422 develops a pulse train of a series of short signals in response to the programmin~
device 420, the signals from the logic unit beinq ~ery -~
short so that they are substantially less than ~he natural period of vibration for armature (not shown) of the solenoid valve. With such an arrangement, all opening cycles of the solenoid valve would be established by the above noted natural period of vibration. The logic unit 422 would then be employed to generate the number o~ such pulses corresponding to a count previously stored in the programming device 420.
Such a series of pulses would be produced for each programmed clock period established by the continuously operating timing unit 424.
Alternatively, in a single pulse mode, the transistor switch 412 could be turned on for a period to assure actuation of the solenoid valve. The currellt delivered to the magnet 416 could then be reduced ~o a load level sufficient for holding the valve in an open condition or else a series of current pulses could be delivered, each pulse being much shorter than the time constant of the magnet. With a relatively long time constant or the magnet, such pulses would cause little fluctuation of the effective current. Such an arrangement is a standard means for lowering the effective DC circuit voltage without high dissipation.
In this mode of operation, such a reduced "holding current" would be maintained for a programmed number of clock pulses and as established by the timing unit 424 after which the logic unit 422 would te~minate the signal through the drive amplifier 418 with the transistor switch 412 being closed to deactuate the solenoid valve.
It is believed apparent that numerous modifications and variations are possible within the scope of the present invention as defined by the various embodiments set forth above. Accordingly, the scope of ,t~J~
the present invention is defined only by the following appended claims.
Claims (4)
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. An implantable infusion device for delivering precisely regulated dosages of drugs under external control, comprising:
a housing for the infusion device which is completely implantable within the body of a patient, said housing including a reservoir chamber and a compressible reservoir arranged in said reservoir chamber for containing a selected drug, catheter means for connecting said reservoir with a portion of the body to which the drug is to be delivered, said housing including a pumping chamber having inlet means in communication with said reservoir and outlet means in communication with said catheter, and actuating means operable for causing flow of a precise dosage of the selected drug from said reservoir through said catheter means to the body portion, said actuating means having at least a portion implanted in the body of the patient along with said housing and including a movable element operable reciprocally to vary the volume of said pumping chamber and a solenoid for driving said element, said reservoir chamber containing means for developing a pressure within said reservoir which exceeds ..
that of said pumping chamber when said movable element increases the volume thereof, a power source for said solenoid, and telemetry means responsive to a telemetered signal from outside the body for actuating said solenoid from said power source.
a housing for the infusion device which is completely implantable within the body of a patient, said housing including a reservoir chamber and a compressible reservoir arranged in said reservoir chamber for containing a selected drug, catheter means for connecting said reservoir with a portion of the body to which the drug is to be delivered, said housing including a pumping chamber having inlet means in communication with said reservoir and outlet means in communication with said catheter, and actuating means operable for causing flow of a precise dosage of the selected drug from said reservoir through said catheter means to the body portion, said actuating means having at least a portion implanted in the body of the patient along with said housing and including a movable element operable reciprocally to vary the volume of said pumping chamber and a solenoid for driving said element, said reservoir chamber containing means for developing a pressure within said reservoir which exceeds ..
that of said pumping chamber when said movable element increases the volume thereof, a power source for said solenoid, and telemetry means responsive to a telemetered signal from outside the body for actuating said solenoid from said power source.
2. The infusion device of Claim 1 further comprising safety latch means engageable with said movable element for preventing undesired operation of said movable means.
3. The infusion device of Claim 1 further comprising means for permitting injection of a drug supply into said reservoir while the infusion device is implanted within the body of a patient.
4. The implantable infusion device of Claim 1 wherein said housing includes a plurality of outlet chambers arranged in series between said pumping chamber and said catheter means, and check valve means for regulating communication between said pumping chamber and the first of said outlet chambers and between adjacent outlet chambers.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/015,927 US4265241A (en) | 1979-02-28 | 1979-02-28 | Implantable infusion device |
| US15,927 | 1979-02-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1139174A true CA1139174A (en) | 1983-01-11 |
Family
ID=21774386
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000346522A Expired CA1139174A (en) | 1979-02-28 | 1980-02-27 | Implantable infusion device |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4265241A (en) |
| EP (1) | EP0024420B1 (en) |
| JP (1) | JPS56500241A (en) |
| AT (1) | ATE9269T1 (en) |
| AU (1) | AU530298B2 (en) |
| CA (1) | CA1139174A (en) |
| DE (1) | DE3069123D1 (en) |
| DK (1) | DK455180A (en) |
| ES (1) | ES488986A0 (en) |
| FI (1) | FI73132C (en) |
| NO (1) | NO148584C (en) |
| WO (1) | WO1980001755A1 (en) |
Families Citing this family (220)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4360019A (en) * | 1979-02-28 | 1982-11-23 | Andros Incorporated | Implantable infusion device |
| US4525165A (en) * | 1979-04-27 | 1985-06-25 | The Johns Hopkins University | Fluid handling system for medication infusion system |
| US4692147A (en) * | 1980-04-02 | 1987-09-08 | Medtronic, Inc. | Drug administration device |
| DE3035670A1 (en) * | 1980-09-22 | 1982-04-29 | Siemens AG, 1000 Berlin und 8000 München | DEVICE FOR INFUSING LIQUIDS IN HUMAN OR ANIMAL BODIES |
| CA1178865A (en) * | 1981-04-10 | 1984-12-04 | William B. Mayfield | Medication infusion device |
| US4557728A (en) * | 1982-05-21 | 1985-12-10 | Repro-Med Systems, Inc. | Spring-operated liquid-dispensing device |
| US4447232A (en) * | 1982-05-21 | 1984-05-08 | Repro-Med Systems, Inc. | Spring-operated liquid-dispensing device |
| ATE30116T1 (en) * | 1982-07-15 | 1987-10-15 | Ferring Biotechnik | DEVICE FOR ADMINISTRATION OF LIQUID MEDICATIONS. |
| GB2131496B (en) * | 1982-12-08 | 1986-09-10 | Moog Inc | Apparatus for dispensing infusate to a mammal body |
| US4557726A (en) * | 1982-12-27 | 1985-12-10 | Consolidated Controls Corporation | Precision medication dispensing system and method |
| US4581018A (en) * | 1983-02-08 | 1986-04-08 | Novacor Medical Corporation | Implantable infusion device |
| US4557722A (en) * | 1983-04-13 | 1985-12-10 | Cordis Corporation | Fill port for an implantable dispensing system |
| FR2551350B1 (en) * | 1983-09-02 | 1985-10-25 | Buffet Jacques | FLUID INJECTION DEVICE, SUITABLE FOR IMPLANTATION |
| US4604090A (en) * | 1983-11-22 | 1986-08-05 | Consolidated Controls Corporation | Compact implantable medication infusion device |
| US4572168A (en) * | 1983-12-20 | 1986-02-25 | Fischell Robert | Fully implantable vapor pressure actuated penile erection device and method |
| US4661097A (en) * | 1984-06-01 | 1987-04-28 | The Johns Hopkins University | Method for clearing a gas bubble from a positive displacement pump contained within a fluid dispensing system |
| DE3577039D1 (en) * | 1984-06-21 | 1990-05-17 | David R Fischell | FINGER-ACTUATED INFUSION SYSTEM FOR THE MEDICAL SUPPLY. |
| US4634427A (en) * | 1984-09-04 | 1987-01-06 | American Hospital Supply Company | Implantable demand medication delivery assembly |
| US4666430A (en) * | 1984-12-05 | 1987-05-19 | I-Flow Corporation | Infusion pump |
| IT1177490B (en) * | 1984-12-21 | 1987-08-26 | Sonda Srl | BUMPER PROTECTIVE PADDING ELEMENT |
| US4714462A (en) * | 1986-02-03 | 1987-12-22 | Intermedics Infusaid, Inc. | Positive pressure programmable infusion pump |
| AT384737B (en) * | 1986-04-04 | 1987-12-28 | Thoma Dipl Ing Dr Techn Herwig | DEVICE FOR CONTINUOUSLY DELIVERING LIQUID MEDICINAL PRODUCTS |
| US4813937A (en) * | 1986-05-07 | 1989-03-21 | Vaillancourt Vincent L | Ambulatory disposable infusion delivery system |
| US4766889A (en) * | 1986-06-26 | 1988-08-30 | Medical Engineering Corporation | Infusion erectile system |
| US4715852A (en) * | 1986-07-21 | 1987-12-29 | Eaton Corporation | Implanted medication infusion device |
| US4773900A (en) * | 1986-08-20 | 1988-09-27 | Cochran Ulrich D | Infusion device |
| US4781689A (en) * | 1986-11-13 | 1988-11-01 | Andrew Sealfon | Spring-operated liquid-dispensing device |
| US4741736A (en) * | 1986-12-10 | 1988-05-03 | I-Flow Corporation | Programmable infusion pump |
| AT391998B (en) * | 1987-02-02 | 1990-12-27 | Falko Dr Skrabal | Device for determining the concentration of at least one medicinal substance in living organisms |
| US4781548A (en) * | 1987-04-10 | 1988-11-01 | Alderson Richard K | Infusion pump system and conduit therefor |
| US5073094A (en) * | 1987-11-17 | 1991-12-17 | Regents Of The University Of Minnesota | Zero net external displacement implantable pump and driver |
| US5006997A (en) * | 1987-12-15 | 1991-04-09 | Shiley Infusaid, Inc. | Pump diagnostic system |
| US5053031A (en) * | 1988-03-29 | 1991-10-01 | Baxter International Inc. | Pump infusion system |
| US4898585A (en) * | 1988-05-18 | 1990-02-06 | Baxter Healthcare Corporation | Implantable patient-activated fluid delivery device with bolus injection port |
| US4898584A (en) * | 1988-05-18 | 1990-02-06 | Baxter Healthcare Corporation | Implantable patient-activated fluid delivery device |
| US4898583A (en) * | 1988-05-18 | 1990-02-06 | Baxter Healthcare Corporation | Implantable patient-activated fluid delivery device and outlet valve therefor |
| US4929236A (en) * | 1988-05-26 | 1990-05-29 | Shiley Infusaid, Inc. | Snap-lock fitting catheter for an implantable device |
| US5011472A (en) * | 1988-09-06 | 1991-04-30 | Brown University Research Foundation | Implantable delivery system for biological factors |
| US5167631A (en) * | 1991-09-17 | 1992-12-01 | Imed Corporation | Portable infusion device |
| US6358239B1 (en) | 1992-01-24 | 2002-03-19 | I-Flow Corporation | Platen pump |
| US5911716A (en) * | 1992-01-24 | 1999-06-15 | I-Flow Corporation | Platen pump |
| US6251098B1 (en) | 1992-01-24 | 2001-06-26 | I-Flow, Corp. | Fluid container for use with platen pump |
| US20080215029A1 (en) * | 1993-01-22 | 2008-09-04 | I-Flow Corporation | Platen pump |
| DE69625831T2 (en) * | 1995-03-23 | 2003-11-20 | Advanced Animal Technology Ltd | Device for administering a substance |
| US6962579B2 (en) * | 1995-03-23 | 2005-11-08 | Advanced Animal Technology Limited | Substance delivery device |
| US5607418A (en) * | 1995-08-22 | 1997-03-04 | Illinois Institute Of Technology | Implantable drug delivery apparatus |
| WO1997027829A1 (en) * | 1996-01-31 | 1997-08-07 | The Trustees Of The University Of Pennsylvania | Remote control drug delivery device |
| US5976109A (en) * | 1996-04-30 | 1999-11-02 | Medtronic, Inc. | Apparatus for drug infusion implanted within a living body |
| US6171298B1 (en) * | 1996-05-03 | 2001-01-09 | Situs Corporation | Intravesical infuser |
| US5785688A (en) * | 1996-05-07 | 1998-07-28 | Ceramatec, Inc. | Fluid delivery apparatus and method |
| US5845646A (en) * | 1996-11-05 | 1998-12-08 | Lemelson; Jerome | System and method for treating select tissue in a living being |
| US6183461B1 (en) | 1998-03-11 | 2001-02-06 | Situs Corporation | Method for delivering a medication |
| US6406455B1 (en) * | 1998-12-18 | 2002-06-18 | Biovalve Technologies, Inc. | Injection devices |
| US6541021B1 (en) * | 1999-03-18 | 2003-04-01 | Durect Corporation | Devices and methods for pain management |
| US6464671B1 (en) * | 1999-04-28 | 2002-10-15 | Sten-Olof Elver | Medical system |
| US6139535A (en) * | 1999-05-27 | 2000-10-31 | Situs Corporation | Method and apparatus for placement and activation of a medical device within a body cavity |
| US6464628B1 (en) | 1999-08-12 | 2002-10-15 | Obtech Medical Ag | Mechanical anal incontinence |
| US6503189B1 (en) | 1999-08-12 | 2003-01-07 | Obtech Medical Ag | Controlled anal incontinence disease treatment |
| US6482145B1 (en) | 2000-02-14 | 2002-11-19 | Obtech Medical Ag | Hydraulic anal incontinence treatment |
| US6471635B1 (en) | 2000-02-10 | 2002-10-29 | Obtech Medical Ag | Anal incontinence disease treatment with controlled wireless energy supply |
| US6406426B1 (en) | 1999-11-03 | 2002-06-18 | Criticare Systems | Medical monitoring and alert system for use with therapeutic devices |
| WO2001051109A1 (en) * | 2000-01-07 | 2001-07-19 | Biovalve Technologies, Inc. | Injection device |
| US6629954B1 (en) | 2000-01-31 | 2003-10-07 | Medtronic, Inc. | Drug delivery pump with isolated hydraulic metering |
| CA2398496C (en) | 2000-02-10 | 2009-05-19 | Surgical Development Ag | Urinary incontinence treatment with wireless energy supply |
| DE60135257D1 (en) | 2000-02-10 | 2008-09-18 | Potencia Medical Ag | Mechanical device for impotence treatment |
| CN1202784C (en) | 2000-02-10 | 2005-05-25 | 波滕西亚医疗公司 | Controlled urinary incontinence treatment |
| AU778406B2 (en) * | 2000-02-11 | 2004-12-02 | Potentica Ag | Controlled impotence treatment |
| CN1400888A (en) * | 2000-02-11 | 2003-03-05 | 波滕西亚医疗公司 | Impotence treatment apparatus with energy transforming means |
| WO2001047440A2 (en) | 2000-02-14 | 2001-07-05 | Potencia Medical Ag | Male impotence prosthesis apparatus with wireless energy supply |
| ATE296071T1 (en) | 2000-02-14 | 2005-06-15 | Potencia Medical Ag | PENIS PROSTHESIS |
| US20030100929A1 (en) | 2000-02-14 | 2003-05-29 | Peter Forsell | Controlled penile prosthesis |
| CA2423717A1 (en) * | 2000-10-04 | 2002-04-11 | Insulet Corporation | Data collection assembly for patient infusion system |
| US6628989B1 (en) * | 2000-10-16 | 2003-09-30 | Remon Medical Technologies, Ltd. | Acoustic switch and apparatus and methods for using acoustic switches within a body |
| WO2002051470A2 (en) * | 2000-11-30 | 2002-07-04 | Biovalve Technologies, Inc. | Injection systems |
| US7201746B2 (en) * | 2001-04-10 | 2007-04-10 | Medtronic, Inc. | Implantable therapeutic substance delivery device having a piston pump with an anti-cavitation valve |
| DE20122407U1 (en) | 2001-04-26 | 2005-09-15 | Groening Ruediger | Pump for administering medicaments to a human or an animal at a rate variable with time is controlled entirely or partially by means of at least one profile located on various elements |
| DE10121004C1 (en) * | 2001-04-28 | 2002-10-31 | Draeger Medical Ag | Anesthetic agent metering |
| RU2279898C2 (en) * | 2002-02-18 | 2006-07-20 | Данфосс А/С | Device for introducing liquid medicaments |
| US6974587B2 (en) * | 2002-05-08 | 2005-12-13 | Aircom Manufacturing, Inc. | Intraruminal device |
| US7008403B1 (en) * | 2002-07-19 | 2006-03-07 | Cognitive Ventures Corporation | Infusion pump and method for use |
| WO2004009160A1 (en) * | 2002-07-24 | 2004-01-29 | M 2 Medical A/S | An infusion pump system, an infusion pump unit and an infusion pump |
| US20050160858A1 (en) * | 2002-07-24 | 2005-07-28 | M 2 Medical A/S | Shape memory alloy actuator |
| US7563244B2 (en) * | 2002-10-31 | 2009-07-21 | Hewlett-Packard Development Company, L.P. | Device for mixing and delivering pharmaceutical compositions |
| JP2006504476A (en) | 2002-11-05 | 2006-02-09 | エム２・メディカル・アクティーゼルスカブ | Disposable, wearable insulin administration device, combination of the device and program control device, and operation control method of the device |
| EP1583571B1 (en) | 2002-12-23 | 2008-02-13 | M2 Medical A/S | Medical dispensing device for insulin |
| EP1583573B1 (en) * | 2002-12-23 | 2011-02-16 | Asante Solutions, Inc. | Flexible piston rod |
| WO2004087237A2 (en) * | 2003-03-27 | 2004-10-14 | Medical Research Products-A, Inc. | Implantable medication delivery device using pressure regulator |
| AU2004232858B2 (en) | 2003-04-23 | 2009-07-09 | Mannkind Corporation | Hydraulically actuated pump for long duration medicament administration |
| US20040220551A1 (en) * | 2003-04-30 | 2004-11-04 | Flaherty J. Christopher | Low profile components for patient infusion device |
| WO2005002642A2 (en) * | 2003-06-25 | 2005-01-13 | Medical Research Products-A, Inc. | Medication infusion device using negatively biased ambient pressure medication chamber |
| US7220244B2 (en) * | 2003-08-04 | 2007-05-22 | Bioquiddity, Inc. | Infusion apparatus with constant force spring energy source |
| WO2005072794A2 (en) * | 2004-01-29 | 2005-08-11 | M 2 Medical A/S | Disposable medicine dispensing device |
| US20050277884A1 (en) * | 2004-05-26 | 2005-12-15 | Kriesel Marshall S | Fluid delivery apparatus with bellows reservoir |
| US20070156090A1 (en) * | 2004-05-26 | 2007-07-05 | Kriesel Marshall S | Fluid delivery apparatus |
| DE102004026805A1 (en) * | 2004-06-02 | 2006-01-05 | Disetronic Licensing Ag | Container for storing a product to be injected and injection device |
| WO2006014425A1 (en) | 2004-07-02 | 2006-02-09 | Biovalve Technologies, Inc. | Methods and devices for delivering glp-1 and uses thereof |
| US7775966B2 (en) | 2005-02-24 | 2010-08-17 | Ethicon Endo-Surgery, Inc. | Non-invasive pressure measurement in a fluid adjustable restrictive device |
| US7775215B2 (en) | 2005-02-24 | 2010-08-17 | Ethicon Endo-Surgery, Inc. | System and method for determining implanted device positioning and obtaining pressure data |
| US7927270B2 (en) | 2005-02-24 | 2011-04-19 | Ethicon Endo-Surgery, Inc. | External mechanical pressure sensor for gastric band pressure measurements |
| US7699770B2 (en) | 2005-02-24 | 2010-04-20 | Ethicon Endo-Surgery, Inc. | Device for non-invasive measurement of fluid pressure in an adjustable restriction device |
| US7658196B2 (en) | 2005-02-24 | 2010-02-09 | Ethicon Endo-Surgery, Inc. | System and method for determining implanted device orientation |
| US8016744B2 (en) | 2005-02-24 | 2011-09-13 | Ethicon Endo-Surgery, Inc. | External pressure-based gastric band adjustment system and method |
| US8066629B2 (en) | 2005-02-24 | 2011-11-29 | Ethicon Endo-Surgery, Inc. | Apparatus for adjustment and sensing of gastric band pressure |
| EP1877115A1 (en) | 2005-04-06 | 2008-01-16 | M 2 Medical A/S | An actuator |
| WO2006127508A2 (en) * | 2005-05-20 | 2006-11-30 | Wilson Greatbatch Technologies Inc. | Improved configuration for drug delivery systems |
| US8551046B2 (en) | 2006-09-18 | 2013-10-08 | Asante Solutions, Inc. | Dispensing fluid from an infusion pump system |
| US8105279B2 (en) | 2005-09-26 | 2012-01-31 | M2 Group Holdings, Inc. | Dispensing fluid from an infusion pump system |
| US8057436B2 (en) * | 2005-09-26 | 2011-11-15 | Asante Solutions, Inc. | Dispensing fluid from an infusion pump system |
| US8409142B2 (en) | 2005-09-26 | 2013-04-02 | Asante Solutions, Inc. | Operating an infusion pump system |
| EP1933902B1 (en) * | 2005-09-26 | 2014-12-17 | Asante Solutions, Inc. | Infusion pump with a drive having a ratchet and pawl combination |
| US7534226B2 (en) | 2005-09-26 | 2009-05-19 | M2 Group Holdings, Inc. | Dispensing fluid from an infusion pump system |
| US8113244B2 (en) | 2006-02-09 | 2012-02-14 | Deka Products Limited Partnership | Adhesive and peripheral systems and methods for medical devices |
| US8852164B2 (en) | 2006-02-09 | 2014-10-07 | Deka Products Limited Partnership | Method and system for shape-memory alloy wire control |
| EP2926847B1 (en) * | 2005-11-02 | 2022-05-25 | MedicalTree Patents Ltd. | Implantable infusion device with advanceable and retractable needle |
| WO2007056592A2 (en) | 2005-11-08 | 2007-05-18 | M2 Medical A/S | Method and system for manual and autonomous control of an infusion pump |
| US8475408B2 (en) * | 2005-11-08 | 2013-07-02 | Asante Solutions, Inc. | Infusion pump system |
| US11478623B2 (en) | 2006-02-09 | 2022-10-25 | Deka Products Limited Partnership | Infusion pump assembly |
| US11364335B2 (en) | 2006-02-09 | 2022-06-21 | Deka Products Limited Partnership | Apparatus, system and method for fluid delivery |
| US11497846B2 (en) | 2006-02-09 | 2022-11-15 | Deka Products Limited Partnership | Patch-sized fluid delivery systems and methods |
| US8579884B2 (en) | 2006-02-09 | 2013-11-12 | Deka Products Limited Partnership | Infusion pump assembly |
| US9492606B2 (en) | 2006-02-09 | 2016-11-15 | Deka Products Limited Partnership | Apparatus, system and methods for an infusion pump assembly |
| WO2007106557A2 (en) * | 2006-03-14 | 2007-09-20 | University Of Southern California | Mems device for delivery of therapeutic agents |
| JP2009532117A (en) | 2006-03-30 | 2009-09-10 | ヴァレリタス，エルエルシー | Multi-cartridge fluid dispensing device |
| US8870742B2 (en) | 2006-04-06 | 2014-10-28 | Ethicon Endo-Surgery, Inc. | GUI for an implantable restriction device and a data logger |
| US8152710B2 (en) | 2006-04-06 | 2012-04-10 | Ethicon Endo-Surgery, Inc. | Physiological parameter analysis for an implantable restriction device and a data logger |
| US8323267B2 (en) * | 2006-04-27 | 2012-12-04 | Medtronic, Inc. | Infusion device with active and passive check valves |
| US20080195083A1 (en) * | 2007-01-31 | 2008-08-14 | Michael Axelsson | Implantable bolus injector |
| US7892199B2 (en) * | 2007-05-21 | 2011-02-22 | Asante Solutions, Inc. | Occlusion sensing for an infusion pump |
| US7981102B2 (en) | 2007-05-21 | 2011-07-19 | Asante Solutions, Inc. | Removable controller for an infusion pump |
| US7833196B2 (en) * | 2007-05-21 | 2010-11-16 | Asante Solutions, Inc. | Illumination instrument for an infusion pump |
| US7794426B2 (en) * | 2007-05-21 | 2010-09-14 | Asante Solutions, Inc. | Infusion pump system with contamination-resistant features |
| US7717903B2 (en) | 2007-09-06 | 2010-05-18 | M2 Group Holdings, Inc. | Operating an infusion pump system |
| US7828528B2 (en) * | 2007-09-06 | 2010-11-09 | Asante Solutions, Inc. | Occlusion sensing system for infusion pumps |
| US8287514B2 (en) | 2007-09-07 | 2012-10-16 | Asante Solutions, Inc. | Power management techniques for an infusion pump system |
| US7879026B2 (en) | 2007-09-07 | 2011-02-01 | Asante Solutions, Inc. | Controlled adjustment of medicine dispensation from an infusion pump device |
| US7935076B2 (en) | 2007-09-07 | 2011-05-03 | Asante Solutions, Inc. | Activity sensing techniques for an infusion pump system |
| US8032226B2 (en) | 2007-09-07 | 2011-10-04 | Asante Solutions, Inc. | User profile backup system for an infusion pump device |
| DE102007049446A1 (en) | 2007-10-16 | 2009-04-23 | Cequr Aps | Catheter introducer |
| US8187163B2 (en) | 2007-12-10 | 2012-05-29 | Ethicon Endo-Surgery, Inc. | Methods for implanting a gastric restriction device |
| US8100870B2 (en) | 2007-12-14 | 2012-01-24 | Ethicon Endo-Surgery, Inc. | Adjustable height gastric restriction devices and methods |
| EP2242464B2 (en) | 2007-12-20 | 2017-03-01 | University Of Southern California | Apparatus for delivering therapeutic agents |
| US8377079B2 (en) | 2007-12-27 | 2013-02-19 | Ethicon Endo-Surgery, Inc. | Constant force mechanisms for regulating restriction devices |
| US8142452B2 (en) | 2007-12-27 | 2012-03-27 | Ethicon Endo-Surgery, Inc. | Controlling pressure in adjustable restriction devices |
| US10188787B2 (en) | 2007-12-31 | 2019-01-29 | Deka Products Limited Partnership | Apparatus, system and method for fluid delivery |
| WO2009088956A2 (en) | 2007-12-31 | 2009-07-16 | Deka Products Limited Partnership | Infusion pump assembly |
| BR122019016154B8 (en) * | 2007-12-31 | 2021-06-22 | Deka Products Lp | infusion pump set |
| US9456955B2 (en) | 2007-12-31 | 2016-10-04 | Deka Products Limited Partnership | Apparatus, system and method for fluid delivery |
| US10080704B2 (en) | 2007-12-31 | 2018-09-25 | Deka Products Limited Partnership | Apparatus, system and method for fluid delivery |
| US8881774B2 (en) | 2007-12-31 | 2014-11-11 | Deka Research & Development Corp. | Apparatus, system and method for fluid delivery |
| US8900188B2 (en) | 2007-12-31 | 2014-12-02 | Deka Products Limited Partnership | Split ring resonator antenna adapted for use in wirelessly controlled medical device |
| US8986253B2 (en) | 2008-01-25 | 2015-03-24 | Tandem Diabetes Care, Inc. | Two chamber pumps and related methods |
| US20090191067A1 (en) * | 2008-01-25 | 2009-07-30 | Phluid,Inc. | Two chamber pumps and related methods |
| US8591395B2 (en) | 2008-01-28 | 2013-11-26 | Ethicon Endo-Surgery, Inc. | Gastric restriction device data handling devices and methods |
| EP3964243A1 (en) | 2008-01-28 | 2022-03-09 | Implantica Patent Ltd | Blood clot removal device, system, and method |
| US8192350B2 (en) | 2008-01-28 | 2012-06-05 | Ethicon Endo-Surgery, Inc. | Methods and devices for measuring impedance in a gastric restriction system |
| US8337389B2 (en) | 2008-01-28 | 2012-12-25 | Ethicon Endo-Surgery, Inc. | Methods and devices for diagnosing performance of a gastric restriction system |
| BRPI0906746A8 (en) | 2008-01-29 | 2019-05-14 | Implantica Patent Ltd | apparatus for treating gastresophageal reflux disease |
| US7844342B2 (en) | 2008-02-07 | 2010-11-30 | Ethicon Endo-Surgery, Inc. | Powering implantable restriction systems using light |
| US8221439B2 (en) | 2008-02-07 | 2012-07-17 | Ethicon Endo-Surgery, Inc. | Powering implantable restriction systems using kinetic motion |
| US8114345B2 (en) | 2008-02-08 | 2012-02-14 | Ethicon Endo-Surgery, Inc. | System and method of sterilizing an implantable medical device |
| US8591532B2 (en) | 2008-02-12 | 2013-11-26 | Ethicon Endo-Sugery, Inc. | Automatically adjusting band system |
| US8057492B2 (en) | 2008-02-12 | 2011-11-15 | Ethicon Endo-Surgery, Inc. | Automatically adjusting band system with MEMS pump |
| US8034065B2 (en) | 2008-02-26 | 2011-10-11 | Ethicon Endo-Surgery, Inc. | Controlling pressure in adjustable restriction devices |
| US8187162B2 (en) | 2008-03-06 | 2012-05-29 | Ethicon Endo-Surgery, Inc. | Reorientation port |
| US8233995B2 (en) | 2008-03-06 | 2012-07-31 | Ethicon Endo-Surgery, Inc. | System and method of aligning an implantable antenna |
| CN102202708B (en) | 2008-05-08 | 2015-01-21 | 迷你泵有限责任公司 | Drug-delivery pumps and methods of manufacture |
| US8056582B2 (en) * | 2008-08-08 | 2011-11-15 | Tandem Diabetes Care, Inc. | System of stepped flow rate regulation using compressible members |
| US7959598B2 (en) | 2008-08-20 | 2011-06-14 | Asante Solutions, Inc. | Infusion pump systems and methods |
| CA2954728C (en) * | 2008-09-15 | 2019-03-26 | Deka Products Limited Partnership | Systems and methods for fluid delivery |
| US8408421B2 (en) | 2008-09-16 | 2013-04-02 | Tandem Diabetes Care, Inc. | Flow regulating stopcocks and related methods |
| US8650937B2 (en) | 2008-09-19 | 2014-02-18 | Tandem Diabetes Care, Inc. | Solute concentration measurement device and related methods |
| US8874215B2 (en) | 2008-10-10 | 2014-10-28 | Peter Forsell | System, an apparatus, and a method for treating a sexual dysfunctional female patient |
| EP2349170B1 (en) | 2008-10-10 | 2023-09-27 | Implantica Patent Ltd. | Apparatus for the treatment of female sexual dysfunction |
| US11123171B2 (en) | 2008-10-10 | 2021-09-21 | Peter Forsell | Fastening means for implantable medical control assembly |
| EP2349096B1 (en) | 2008-10-10 | 2021-01-27 | MedicalTree Patent Ltd. | An improved artificial valve |
| US9072907B2 (en) | 2008-10-10 | 2015-07-07 | Peter Forsell | Heart help device, system, and method |
| ES2950024T3 (en) | 2008-10-10 | 2023-10-04 | Medicaltree Patent Ltd | Heart support device, system and procedure |
| US8100890B2 (en) * | 2008-10-15 | 2012-01-24 | Bioquiddity, Inc. | Special purpose fluid dispenser with pre-filled reservoir |
| US7896843B2 (en) * | 2008-10-15 | 2011-03-01 | Bioquiddity, Inc. | Special purpose fluid dispenser |
| US20100121274A1 (en) * | 2008-11-12 | 2010-05-13 | Baxter International Inc. | Prefillable constant pressure ambulatory infusion pump |
| AU2010217760B2 (en) | 2009-02-27 | 2015-04-09 | Tandem Diabetes Care, Inc. | Methods and devices for determination of flow reservoir volume |
| US9250106B2 (en) | 2009-02-27 | 2016-02-02 | Tandem Diabetes Care, Inc. | Methods and devices for determination of flow reservoir volume |
| US8721605B2 (en) | 2009-04-27 | 2014-05-13 | The Alfred E. Mann Foundation For Scientific Research | Implantable infusion devices with palpable landmarks and methods of needle detection |
| US9949812B2 (en) | 2009-07-17 | 2018-04-24 | Peter Forsell | Vaginal operation method for the treatment of anal incontinence in women |
| US10952836B2 (en) | 2009-07-17 | 2021-03-23 | Peter Forsell | Vaginal operation method for the treatment of urinary incontinence in women |
| CA2769030C (en) | 2009-07-30 | 2016-05-10 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
| EP3085402B1 (en) | 2009-12-31 | 2018-05-09 | DEKA Products Limited Partnership | Infusion pump assembley |
| EP2531232B1 (en) | 2010-02-05 | 2016-10-19 | DEKA Products Limited Partnership | Infusion pump apparatus and heated fill adapter system |
| US11660392B2 (en) | 2010-02-05 | 2023-05-30 | Deka Products Limited Partnership | Devices, methods and systems for wireless control of medical devices |
| US9662438B2 (en) | 2010-02-05 | 2017-05-30 | Deka Products Limited Partnership | Devices, methods and systems for wireless control of medical devices |
| NL1037733C2 (en) * | 2010-02-22 | 2011-08-23 | Yusuf Galipoglu | PORTABLE MECHANICAL CAN FOR LIQUID FABRIC AND INFUSION SYSTEM. |
| LT3184136T (en) * | 2010-03-25 | 2021-10-11 | New Injection Systems Ltd | Injector |
| USD669165S1 (en) | 2010-05-27 | 2012-10-16 | Asante Solutions, Inc. | Infusion pump |
| US9211378B2 (en) | 2010-10-22 | 2015-12-15 | Cequr Sa | Methods and systems for dosing a medicament |
| US8852152B2 (en) | 2011-02-09 | 2014-10-07 | Asante Solutions, Inc. | Infusion pump systems and methods |
| WO2012145343A2 (en) * | 2011-04-18 | 2012-10-26 | Kuvio, Inc. | Drug delivery device with compressible fluid chambers |
| US8585657B2 (en) | 2011-06-21 | 2013-11-19 | Asante Solutions, Inc. | Dispensing fluid from an infusion pump system |
| US11524151B2 (en) | 2012-03-07 | 2022-12-13 | Deka Products Limited Partnership | Apparatus, system and method for fluid delivery |
| US9180242B2 (en) | 2012-05-17 | 2015-11-10 | Tandem Diabetes Care, Inc. | Methods and devices for multiple fluid transfer |
| US9555186B2 (en) | 2012-06-05 | 2017-01-31 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
| US9333292B2 (en) * | 2012-06-26 | 2016-05-10 | Medtronic Minimed, Inc. | Mechanically actuated fluid infusion device |
| AU2013349611B2 (en) | 2012-11-23 | 2018-05-31 | Sensile Medical Ag | Auto-injector assembly |
| US9173998B2 (en) | 2013-03-14 | 2015-11-03 | Tandem Diabetes Care, Inc. | System and method for detecting occlusions in an infusion pump |
| CA3130345A1 (en) | 2013-07-03 | 2015-01-08 | Deka Products Limited Partnership | Apparatus, system and method for fluid delivery |
| US9561324B2 (en) | 2013-07-19 | 2017-02-07 | Bigfoot Biomedical, Inc. | Infusion pump system and method |
| US10569015B2 (en) | 2013-12-02 | 2020-02-25 | Bigfoot Biomedical, Inc. | Infusion pump system and method |
| JP2016049313A (en) * | 2014-09-01 | 2016-04-11 | 株式会社アクアテック | Liquid discharge device |
| US9878097B2 (en) | 2015-04-29 | 2018-01-30 | Bigfoot Biomedical, Inc. | Operating an infusion pump system |
| US10716896B2 (en) | 2015-11-24 | 2020-07-21 | Insulet Corporation | Wearable automated medication delivery system |
| US10987468B2 (en) | 2016-01-05 | 2021-04-27 | Bigfoot Biomedical, Inc. | Operating multi-modal medicine delivery systems |
| US10449294B1 (en) | 2016-01-05 | 2019-10-22 | Bigfoot Biomedical, Inc. | Operating an infusion pump system |
| US20190046721A1 (en) * | 2016-02-26 | 2019-02-14 | Progenity Inc. | Compact platform for accurate drug delivery |
| USD809134S1 (en) | 2016-03-10 | 2018-01-30 | Bigfoot Biomedical, Inc. | Infusion pump assembly |
| US10426896B2 (en) | 2016-09-27 | 2019-10-01 | Bigfoot Biomedical, Inc. | Medicine injection and disease management systems, devices, and methods |
| CA3037432A1 (en) | 2016-12-12 | 2018-06-21 | Bigfoot Biomedical, Inc. | Alarms and alerts for medication delivery devices and related systems and methods |
| USD836769S1 (en) | 2016-12-12 | 2018-12-25 | Bigfoot Biomedical, Inc. | Insulin delivery controller |
| USD839294S1 (en) | 2017-06-16 | 2019-01-29 | Bigfoot Biomedical, Inc. | Display screen with graphical user interface for closed-loop medication delivery |
| US11389088B2 (en) | 2017-07-13 | 2022-07-19 | Bigfoot Biomedical, Inc. | Multi-scale display of blood glucose information |
| US11260211B2 (en) * | 2018-02-26 | 2022-03-01 | Primo Medical Group, Inc. | Variable volume infusion port |
| WO2019209963A1 (en) | 2018-04-24 | 2019-10-31 | Deka Products Limited Partnership | Apparatus and system for fluid delivery |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3527220A (en) * | 1968-06-28 | 1970-09-08 | Fairchild Hiller Corp | Implantable drug administrator |
| US3659600A (en) * | 1970-02-24 | 1972-05-02 | Estin Hans H | Magnetically operated capsule for administering drugs |
| US3731681A (en) * | 1970-05-18 | 1973-05-08 | Univ Minnesota | Implantable indusion pump |
| US3692027A (en) * | 1971-04-23 | 1972-09-19 | Everett H Ellinwood Jr | Implanted medication dispensing device and method |
| CH557178A (en) * | 1972-08-10 | 1974-12-31 | Siemens Ag | DEVICE FOR DISPENSING DRUGS. |
| US3827601A (en) * | 1973-03-23 | 1974-08-06 | J Magrath | Hand powered liquid dispenser of the metering type |
| US3923060A (en) * | 1974-04-23 | 1975-12-02 | Jr Everett H Ellinwood | Apparatus and method for implanted self-powered medication dispensing having timing and evaluator means |
| US4003379A (en) * | 1974-04-23 | 1977-01-18 | Ellinwood Jr Everett H | Apparatus and method for implanted self-powered medication dispensing |
| US4013074A (en) * | 1974-06-21 | 1977-03-22 | Siposs George G | Implantable medication-dispensing device |
| JPS5130719U (en) * | 1974-08-29 | 1976-03-05 | ||
| DE2513467C3 (en) * | 1975-03-26 | 1979-10-31 | Siemens Ag, 1000 Berlin Und 8000 Muenchen | Device for infusing liquids into the human or animal body |
| FR2305963A1 (en) * | 1975-04-04 | 1976-10-29 | Anvar | IMPLANTABLE ORDER FOR MEDICAL OR SURGICAL USE |
| US3951147A (en) * | 1975-04-07 | 1976-04-20 | Metal Bellows Company | Implantable infusate pump |
| DE2652026C2 (en) * | 1976-11-15 | 1983-01-05 | Siemens AG, 1000 Berlin und 8000 München | Device for infusing liquids |
| US4152098A (en) * | 1977-01-03 | 1979-05-01 | Clark Ivan P | Micropump |
| US4193397A (en) * | 1977-12-01 | 1980-03-18 | Metal Bellows Corporation | Infusion apparatus and method |
-
1979
- 1979-02-28 US US06/015,927 patent/US4265241A/en not_active Expired - Lifetime
-
1980
- 1980-02-21 AU AU55773/80A patent/AU530298B2/en not_active Ceased
- 1980-02-25 WO PCT/US1980/000176 patent/WO1980001755A1/en active IP Right Grant
- 1980-02-25 DE DE8080900527T patent/DE3069123D1/en not_active Expired
- 1980-02-25 AT AT80900527T patent/ATE9269T1/en not_active IP Right Cessation
- 1980-02-25 JP JP50068480A patent/JPS56500241A/ja active Pending
- 1980-02-26 NO NO800532A patent/NO148584C/en unknown
- 1980-02-27 ES ES488986A patent/ES488986A0/en active Granted
- 1980-02-27 CA CA000346522A patent/CA1139174A/en not_active Expired
- 1980-02-27 FI FI800585A patent/FI73132C/en not_active IP Right Cessation
- 1980-09-10 EP EP80900527A patent/EP0024420B1/en not_active Expired
- 1980-10-28 DK DK455180A patent/DK455180A/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0024420A1 (en) | 1981-03-11 |
| EP0024420A4 (en) | 1981-07-08 |
| NO800532L (en) | 1980-08-29 |
| AU5577380A (en) | 1980-09-04 |
| FI800585A (en) | 1980-08-29 |
| EP0024420B1 (en) | 1984-09-12 |
| AU530298B2 (en) | 1983-07-07 |
| US4265241A (en) | 1981-05-05 |
| FI73132B (en) | 1987-05-29 |
| ES8102812A1 (en) | 1981-02-16 |
| DE3069123D1 (en) | 1984-10-18 |
| DK455180A (en) | 1980-10-28 |
| NO148584B (en) | 1983-08-01 |
| ATE9269T1 (en) | 1984-09-15 |
| ES488986A0 (en) | 1981-02-16 |
| WO1980001755A1 (en) | 1980-09-04 |
| NO148584C (en) | 1983-11-09 |
| FI73132C (en) | 1987-09-10 |
| JPS56500241A (en) | 1981-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1139174A (en) | Implantable infusion device | |
| US4673391A (en) | Non-contact controlled micropump | |
| US6957655B2 (en) | Apparatus for dosage control | |
| US5667504A (en) | Process for the adjustment of a switchable flow limiting apparatus, and an apparatus operating according to the process | |
| US7150741B2 (en) | Programmable dose control module | |
| US8323267B2 (en) | Infusion device with active and passive check valves | |
| US7758568B2 (en) | Implantable therapeutic substance delivery device | |
| US7201746B2 (en) | Implantable therapeutic substance delivery device having a piston pump with an anti-cavitation valve | |
| US4482346A (en) | Apparatus for infusing medication into the body | |
| US7066915B2 (en) | Low profile inlet valve for a piston pump therapeutic substance delivery device | |
| EP0037400B1 (en) | A pump for infusing liquid medicine | |
| US20060206099A1 (en) | Low profile inlet valve for a piston pump therapeutic substance delivery device | |
| JPS59131356A (en) | Implantable injection micro-pump system | |
| CA1156893A (en) | Magnetically controlled drug infusion system | |
| CA1231281A (en) | Inhibiting means for programmable infusion system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |